Ads
related to: bristol-myers squibbscbn.org has been visited by 10K+ users in the past month
Search results
Is It Too Late to Buy Vertex Pharmaceuticals Stock?
Motley Fool via Yahoo Finance· 5 days agoVertex Pharmaceuticals (NASDAQ: VRTX) is a fast-growing pharmaceutical company that investors have been bullish on for years. The business generates...
A year ago, Takeda pledged to create local jobs in exchange for $1.8 million in tax breaks. Now,...
The Boston Globe· 7 hours agoThen last week Takeda said in a filing with the state that it planned to lay off 641 employees in...
Wall Street's Most Accurate Analysts Say Hold These 3 Health Care Stocks With Over 4% Dividend...
Benzinga· 3 days agoLoading... Loading... During times of turbulence and uncertainty in the markets, even when markets...
1st-Quarter Earnings Season Results, Expectations for 2024
GuruFocus.com via Yahoo Finance· 1 day agoFirst-quarter earnings season has become one of the important market supporting factors during...
J&J antidepressant eases symptoms, improves sleep in key trial
BioPharma Dive via Yahoo Finance· 2 days agoDive Brief: A new kind of antidepressant eased symptoms and improved sleep among adults enrolled in...
Biotech faces a reckoning: ‘We've lost our luster in cell therapies’
FierceBiotech· 2 days agoThis story is the first part in a four-part series about cell therapy, created by the Fierce Biotech...
This Pharma Stock Is Poised to Keep Outperforming the S&P 500
The Motley Fool via AOL· 16 hours agoAstraZeneca has quietly delivered market-beating results since 2014. Despite skepticism, the company...
ASCO 2024: Rakuten’s photoimmunotherapy and Keytruda combo shows efficacy in HNSCC
Clinical Trials Arena via Yahoo Finance· 3 days agoUS-based Rakuten Medical has announced positive interim data from the Phase Ib/II trial of its...
What's Going On With Mid-Cap Cancer-Focused Verastem Oncology Stock On Friday?
Benzinga via Yahoo Finance· 7 days agoThursday, Verastem Oncology (NASDAQ:VSTM) announced the initial interim safety and efficacy results...
A 'robust' earnings outlook is driving further optimism for stocks in 2024
AOL· 2 days agoS&P 500 (^GSPC) earnings grew 6% in the first quarter from a year ago, according to data from FactSet. When excluding dismal earnings from Bristol Myers-Squibb (BMY), the results were even better ...